Cancer Efficacy Algorithm
This is a really impressive move forward, I think. The difficulty of applying mathematical formulas to systems as complex as cancerous tissues within the body are mind-boggling, but they have apparently simplified the system with enough assumptions to accurately model this particular scenario. If we can continue this trend, we may face a huge reduction in R&D costs for pharmaceutical companies, which can only mean good things for further investment in new areas and *hopefully* for drugs prices, as well. The medical industry is awfully bloated from abuse on every end of the stick, and it worries me. I can only hope that this development will allow some of that nebulous marketing BS involved in the pharma sales to go away as drugs are literally prescribed based upon mathematical models rather than glitzy marketing or persistence of the sales reps.
Here’s to hoping, anyway…
2 Comments:
I think you may be mistaken. Marketing will always be an issue and a huge financial investment for these guys. More and more doctors are dealing with patients who come in asking about these advertised drugs for imagined illnesses.
No my friend, I think we'll see more marketing as their R&D overhead goes away and more needless sugar pills for imagined illnesses.
By the way, that was from Ted.
Post a Comment
<< Home